agm wrap, page-30

I have been a long term reader about PXS - but am finding it very sad that particular posters have to keep sniping at a stock.


Contrarian views are great, but not when they reflect an ego that just cant let others talk about a stock that they are interested in - that just makes the poster look like a fool.


PXS is difficult as you are buying into a story - an thus trying to value future sales on drugs where we dont know the ultimate useage patterns.


However, there are many medical professionals that own this stock - particularly in areas such as intensive care.

Having seen Bronchitrol used very successfully on a patient (who was not in the usual planned treatment population), I can understand why there has been a lot of interest in the stock.

Before the negative posters come back at this - I realise that a trial of 1 is just that - a trial of one. I also realise that you need more than a successful drug to turn a profit - you need a market for that drug.

But I am happy to invest/trade, watch & wait. The PXS story has the potential to add a very useful drug (that really has no equivalent) to the lives of many people - and in doing so reward the many patient investors. Buying when a stock is down makes a lot more sense than buying at its peak

(I owned PXS from 42,47,140, 160, 240 -> sold half at 430 and the other at 330 on the way down - Have now been buying back at 150 and 160 again)

Is it too much to ask for a meaningful discussion on this stock?

Thanks to all the posters that have made useful contributions.


I